Xenon Pharmaceuticals SG&A Expense (Quarterly) Analysis

Xenon Pharmaceuticals Inc (XENE)

38.41 0.00 (0.00%) USD | NASDAQ | Sep 27, 16:00

38.41 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
June 30, 2024	19.40M
March 31, 2024	14.79M
December 31, 2023	12.62M
September 30, 2023	12.80M
June 30, 2023	11.58M
March 31, 2023	9.535M
December 31, 2022	8.501M
September 30, 2022	8.829M
June 30, 2022	8.705M
March 31, 2022	6.775M
December 31, 2021	6.688M
September 30, 2021	4.831M
June 30, 2021	6.339M
March 31, 2021	4.109M
December 31, 2020	3.106M
September 30, 2020	3.208M
June 30, 2020	3.31M
March 31, 2020	3.32M
December 31, 2019	3.175M
September 30, 2019	2.70M
June 30, 2019	2.307M
March 31, 2019	2.621M

Date	Value
December 31, 2018	2.052M
September 30, 2018	1.938M
June 30, 2018	2.178M
March 31, 2018	2.238M
December 31, 2017	1.67M
September 30, 2017	1.744M
June 30, 2017	1.799M
March 31, 2017	2.10M
December 31, 2016	1.442M
September 30, 2016	1.779M
June 30, 2016	1.676M
March 31, 2016	1.895M
December 31, 2015	1.567M
September 30, 2015	1.321M
June 30, 2015	0.178M
March 31, 2015	6.72M
December 31, 2014	1.39M
September 30, 2014	1.316M
June 30, 2014	1.354M
March 31, 2014	1.436M
December 31, 2013	0.821M
September 30, 2013	1.692M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.70M

Minimum

Sep 2019

19.40M

Maximum

Jun 2024

7.717M

Average

6.732M

Median

SG&A Expense (Quarterly) Benchmarks